BioCentury | Jun 6, 2020
Product Development

AAV COVID-19 vaccine aims for the sweet spot between antibody and T cell immunity

...On May 28, the AAVCOVID team announced manufacturing partnerships with AveXis as well as CDMOs Aldevron LLC...
...which speeds up production and mitigates risk. In one supply line, DNA plasmids produced by Aldevron...
...into the AAV vector, and finally to Catalent for QC. In the second, plasmids from Aldevron...
BioCentury | May 28, 2020
Product Development

Mass General counts AveXis, James Wilson among partners as it readies to deploy gene therapy tools for COVID-19 vaccine

...it formed manufacturing partnerships with the AveXis unit of Novartis AG (NYSE:NVS; SIX:NOVN) and CDMOs Aldevron LLC...
...the study off in later phases to AveXis for manufacturing and additional testing.” The Viralgen, Aldevron...
...chains and workflows can produce hundreds of trillions of viral particles per batch. North Dakota-based Aldevron...
BioCentury | Dec 7, 2018
Tools & Techniques

Germline editing gets technical

...BioMedical Research unit of Novartis AG (NYSE:NVS; SIX:NOVN) Basel, Switzerland Tools, services and diagnostics companies Aldevron LLC...
BioCentury | Jan 2, 2006
Clinical News

CytoGenix preclinical data

...The synDNA is a synthetic DNA vaccine derived from HBV surface antigen plasmid provided by Aldevron LLC...
BioCentury | Oct 24, 2005
Company News

Maxygen, National Institutes of Health, U.S. Department of Defense infectious news

...the funds will be shared with Monogram Biosciences Inc. (MGRM, South San Francisco, Calif.) and Aldevron...
Items per page:
1 - 5 of 5
BioCentury | Jun 6, 2020
Product Development

AAV COVID-19 vaccine aims for the sweet spot between antibody and T cell immunity

...On May 28, the AAVCOVID team announced manufacturing partnerships with AveXis as well as CDMOs Aldevron LLC...
...which speeds up production and mitigates risk. In one supply line, DNA plasmids produced by Aldevron...
...into the AAV vector, and finally to Catalent for QC. In the second, plasmids from Aldevron...
BioCentury | May 28, 2020
Product Development

Mass General counts AveXis, James Wilson among partners as it readies to deploy gene therapy tools for COVID-19 vaccine

...it formed manufacturing partnerships with the AveXis unit of Novartis AG (NYSE:NVS; SIX:NOVN) and CDMOs Aldevron LLC...
...the study off in later phases to AveXis for manufacturing and additional testing.” The Viralgen, Aldevron...
...chains and workflows can produce hundreds of trillions of viral particles per batch. North Dakota-based Aldevron...
BioCentury | Dec 7, 2018
Tools & Techniques

Germline editing gets technical

...BioMedical Research unit of Novartis AG (NYSE:NVS; SIX:NOVN) Basel, Switzerland Tools, services and diagnostics companies Aldevron LLC...
BioCentury | Jan 2, 2006
Clinical News

CytoGenix preclinical data

...The synDNA is a synthetic DNA vaccine derived from HBV surface antigen plasmid provided by Aldevron LLC...
BioCentury | Oct 24, 2005
Company News

Maxygen, National Institutes of Health, U.S. Department of Defense infectious news

...the funds will be shared with Monogram Biosciences Inc. (MGRM, South San Francisco, Calif.) and Aldevron...
Items per page:
1 - 5 of 5